brain-cancer

Documents about brain-cancer

• Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas#901586ClinicalTrials.gov
• NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors#1030787ClinicalTrials.gov
• Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma#831530ClinicalTrials.gov
• Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma#888450ClinicalTrials.gov
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy#902921ClinicalTrials.gov
• Brain Metabolic Activity Measured by [ ¹⁸ F]FDG PET/CT Predicts Survival in Patients with Advanced Non–Small Cell Lung Cancer#159306HAL (France)
• Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma#866500ClinicalTrials.gov
• Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells#876951ClinicalTrials.gov
• Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)#891642ClinicalTrials.gov
• Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma#905931ClinicalTrials.gov
• Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas#855084ClinicalTrials.gov
• Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme#860693ClinicalTrials.gov
• Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT#866001ClinicalTrials.gov
• Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme#879154ClinicalTrials.gov
• Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.#804380ClinicalTrials.gov
• Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia#842745ClinicalTrials.gov
• Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery#912954ClinicalTrials.gov
• Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies#955052Koc University Digital Collections
• Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas#967436ClinicalTrials.gov
• A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma#982278ClinicalTrials.gov
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma#841974ClinicalTrials.gov
• Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme#850497ClinicalTrials.gov
• A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients#913739ClinicalTrials.gov
• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer#829464ClinicalTrials.gov
• Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma#826022ClinicalTrials.gov
• Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma#840645ClinicalTrials.gov
• Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia#845462ClinicalTrials.gov
• Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow#901070ClinicalTrials.gov
• A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors#882733ClinicalTrials.gov
• Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors#856614ClinicalTrials.gov
• Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma#810782ClinicalTrials.gov
• The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer#954628Koc University Digital Collections
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer#893633ClinicalTrials.gov
• Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme#902742ClinicalTrials.gov
• Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases#905162ClinicalTrials.gov
• Corrigendum: Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction#614727eScholarship
• Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma#981962ClinicalTrials.gov
• A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas#992965ClinicalTrials.gov
• First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)#333826HAL (France)
• Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma#848256ClinicalTrials.gov
• A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors#1047833ClinicalTrials.gov
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors#857141ClinicalTrials.gov
• Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy#619956eScholarship
• Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma#850314ClinicalTrials.gov
• Temozolomide in Treating Patients With Invasive Pituitary Tumors#838293ClinicalTrials.gov
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas#992378ClinicalTrials.gov
• RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma#871660ClinicalTrials.gov
• Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors#906014ClinicalTrials.gov
• Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma#184855ClinicalTrials.gov
• Daily patterns of substance use among young adults who vape nicotine and cannabis: Latent class analysis of smartphone-based daily diary data#642061eScholarship